ALBANY MOLECULAR RESEARCH INC — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4550af21-8545-4bee-990a-b48ddd20789f/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2016 | $-18.8M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-015129 |
| FY 2015 | $13.6M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-091051 |
| FY 2014 | $5.7M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-016363 |
| FY 2013 | $20.2M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-016173 |
| FY 2012 | $703.0k | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-015765 |
| FY 2011 | $-36.1M | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-015296 |
| FY 2010 | $-72.0M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-015296 |
| FY 2009 | $-21.7M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-015296 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ALBANY MOLECULAR RESEARCH INC — all facts · Revenue · Net Income